Glauco R. Souza

Glauco R. Souza is an accomplished professional with extensive experience in biotechnology and business development. Currently serving as the Director of Global Business Development & Innovation at Greiner Bio-One International since April 2018, Souza also contributes as a Member of the Board of Directors at ChemoSen3D, Inc. Previous roles include President & CEO at Nano3D Biosciences, where leadership focused on advancing magnetic 3D cell culture and bioprinting technologies, and an Adjunct Assistant Professor at UTHealth. Souza's foundational research at MD Anderson Cancer Center involved utilizing nanotechnology for cancer biomaterials, resulting in multiple patents and significant publications. Educational credentials include a Ph.D. in Physical Chemistry and an MBA focused on Business Analytics, complemented by executive education in AI, Technology, and Innovation from MIT.